
Meera Mohan
Associate Professor, Lymphoma-Myeloma, Cancer Medicine · The University of Texas MD Anderson Cancer Center
Credentials: · · · · · · · · · ·
History

- 2007–2010
DMC Sinai-Grace Internal Medicine Residency
Research
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Blood Cancer Journal · 2024 · Co-first of 21 authors · 95 citations
Case report · British Journal of Haematology · 2023 · First of 10 authors · 81 citations
Risk of infections with B-cell maturation antigen-directed immunotherapy in multiple myeloma
Blood Advances · 2022 · First of 7 authors · Corresponding · 61 citations

39 papers

35 papers

35 papers

26 papers

26 papers

21 papers · 7 as a fellow

16 papers

16 papers · 5 as a fellow
Clinical trials
- 2026–2029
BCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM)
Principal investigator · Not yet recruiting · Phase 2
Medical College of Wisconsin
- 2022–2024
Principal investigator · Terminated · Phase 2
Medical College of Wisconsin



